Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
NCT05368220 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 6500
Last updated 2022-05-17
Summary
The aim of TRANSLATE is to implement genetic information directly into patient care to improve diagnosis and treatment of non-autoimmune diabetes. This project is the first large-scale implementation of systematic genetic testing within a common, non-communicable, chronic disease in Denmark, and will spearhead efforts to advance personalized medicine in Denmark.
The project will contribute to establishing technology, workflow, and evidence on how to implement and communicate actionable genetic information to clinicians and patients in a generalized format. These developments are pivotal for personalized medicine to reach broader clinical application.
Conditions
- Diabetes Mellitus, Type 2
- Diabetes, Gestational
Interventions
- OTHER
-
Whole genome sequencing
Each participant will have WGS performed in order to report on clinically actionable genetic variation in diabetes.
Sponsors & Collaborators
-
Steno Diabetes Center Copenhagen
collaborator OTHER -
BGI Europe
collaborator UNKNOWN -
Intomics A/S
collaborator UNKNOWN -
Rigshospitalet, Denmark
collaborator OTHER -
Danish National Genome Center
collaborator UNKNOWN -
Nordsjaellands Hospital
collaborator OTHER -
Herlev Hospital
collaborator OTHER -
Hvidovre University Hospital
collaborator OTHER -
University of Copenhagen
lead OTHER
Principal Investigators
-
Torben Hansen, PhD · University of Copenhagen
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-06
- Primary Completion
- 2025-05-31
- Completion
- 2027-05-31
Countries
- Denmark
Study Locations
More Related Trials
-
Predisposition Genes in Monogenic Diabetes (DIAMONO)
NCT02634229 ·Status: COMPLETED
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes
NCT02021695 ·Status: COMPLETED
-
Plasma Transthyretin Levels and Risk of Type 2 Diabetes Mellitus and Impaired Glucose Regulation
NCT05370560 ·Status: COMPLETED
-
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
NCT06746610 ·Status: RECRUITING ·Phase: NA
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NCT05147961 ·Status: RECRUITING ·Phase: NA
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Uncovering the 'ORIGINS' of Diabetes
NCT02226640 ·Status: COMPLETED
-
Gene Expression Profiling in Type 1 Diabetes
NCT00330954 ·Status: COMPLETED
-
Subjects With T2D or at Risk of T2D Cohort Follow-up
NCT05567692 ·Status: SUSPENDED
-
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286 ·Status: UNKNOWN ·Phase: NA
-
Type 2 Diabetes Mellitus Collaborative Genetic Study on Non-aboriginal Taiwanese
NCT01250639 ·Status: UNKNOWN
-
Genetic Physiopathology and Evolution of Type 2 Diabetes
NCT00879801 ·Status: COMPLETED
-
Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population
NCT02316522 ·Status: COMPLETED
-
AI Ready and Exploratory Atlas for Diabetes Insights
NCT06002048 ·Status: ENROLLING_BY_INVITATION
-
Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples
NCT04011228 ·Status: UNKNOWN
-
Clinical Characteristics of People With Long-term Type 1 Diabetes
NCT05359796 ·Status: RECRUITING
-
Precise Treatment of Prediabetes and Stage 1 Hypertension
NCT04529590 ·Status: COMPLETED
-
Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229
NCT02267902 ·Status: UNKNOWN ·Phase: PHASE1
-
Epigenetic Modifications of Diabetes Mellitus Type I
NCT01623388 ·Status: WITHDRAWN
-
Natural History of Autoimmune Diabetes and Its Complications
NCT00896610 ·Status: TERMINATED
-
Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
NCT06979037 ·Status: RECRUITING
-
Genomic Study of Young-Onset Diabetes Mellitus
NCT06273059 ·Status: RECRUITING
-
Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project Aalst
NCT00824499 ·Status: UNKNOWN ·Phase: NA